✦ LIBER ✦

G.P.14.06 There is no correlation between muscle strength and myotonia in patients with myotonic dystrophy type 1

✍ Scribed by N. Preisler; M. Cathrine Orngreen; G. Andersen; T. Dysgaard Jeppesen; E. Colding-Jorgensen; T. Clausen; M. Schwartz; M. Duno; J. Vissing

Book ID: 116793163
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 60 KB
Volume: 17
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2007.06.315

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

D.P.2.06 Correlation between measures of

D.P.2.06 Correlation between measures of muscle mass, strength, function and quality of life (QOL) in patients with myotonic dystrophy type 1 (DM1): Implications for clinical trials

✍ S. Pandya; N. Dilek; W. Martens; C. Quinn; C. Thornton; R.T. Moxley 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Creatine monohydrate supplementation doe

Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1

✍ Mark Tarnopolsky; Douglas Mahoney; Terry Thompson; Heather Naylor; Timothy J. Do 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract Creatine monohydrate (CrM) supplementation may increase strength in some types of muscular dystrophy. A recent study in myotonic muscular dystrophy type 1 (DM1) did not find a significant treatment effect, but measurements of muscle phosphocreatine (PCr) were not performed. We completed

G.P.6.05 Test/retest reliability and mac

G.P.6.05 Test/retest reliability and machine/machine correlation of dual energy X-ray absorptiometry (DEXA) measurements in patients with myotonic dystrophy type 1 and 2 (DM-1 and DM-2)

✍ S. Pandya; N. Dilek; W. Martens; C. Thornton; R.T. Moxley 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB